
Fibrinogen–erythrocyte binding and hemorheology measurements in the assessment of essential arterial hypertension patients
2019; Royal Society of Chemistry; Volume: 11; Issue: 6 Linguagem: Inglês
10.1039/c8nr04398a
ISSN2040-3372
AutoresAna Filipa Guedes, C. Santos Moreira, J. Braz Nogueira, Nuno C. Santos, Filomena A. Carvalho,
Tópico(s)Cardiovascular Health and Disease Prevention
ResumoThe stronger fibrinogen binding to erythrocytes from EAH patients may lead to erythrocyte aggregation, representing an important cardiovascular risk factor.
Referência(s)